Education
About Us
Working with TipRanks
Follow Us
Treace Medical Concepts (TMCI)
NASDAQ:TMCI
TMCI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$4.54 - $10.79
Previous CloseN/A
Volume76.56K
Average Volume (3M)493.55K
Market Cap
$420.83M
Enterprise ValueN/A
Total Cash (Recent Filing)$75.68M
Total Debt (Recent Filing)$69.65M
Price to Earnings (P/E)―
Beta1.87
Next Earnings
Aug 12, 2025EPS Estimate
-0.29Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.25
Shares Outstanding62,904,953
10 Day Avg. Volume681,981
30 Day Avg. Volume493,552
Financial Highlights & Ratios
PEG Ratio-1.01
Price to Book (P/B)4.54
Price to Sales (P/S)0.00
P/FCF Ratio-10.57
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$10.35Price Target Upside64.55% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
Treace Medical Concepts News
PremiumCompany Announcements
Treace Medical Elects Directors at Annual Meeting
PremiumCompany Announcements
Treace Medical Concepts’ Earnings Call: Balancing Growth and Challenges
PremiumCompany Announcements
Treace Medical Concepts Reports Q1 2025 Financial ResultsBulls Say, Bears Say
Bulls Say
Financial PerformanceExpense management initiatives resulted in a reduction in operating expenses, contributing to a positive performance below the topline.
Growth PotentialThe foot and ankle orthopedics market is a $5B+ global market growing at a 7%-8% CAGR, offering significant opportunities for attention.
Product InnovationEarly feedback on Treace’s Nanoplasty and Percuplasty solutions is universally positive, attracting previously reluctant surgeons.
Bears Say
Growth ConcernsLapiplasty growth has stalled, raising concerns about the company's growth profile in this area.
Market ChallengesInvestors have experienced multiple significant drawdowns related to softness in bunion procedures and competitive concerns, causing many to move to the sidelines.
Ownership Overview
30.21% Insiders
11.43% Mutual Funds
24.20% Other Institutional Investors
21.62% Public Companies and
Individual Investors
TMCI FAQ
What was Treace Medical Concepts’s price range in the past 12 months?
Treace Medical Concepts lowest stock price was $4.54 and its highest was $10.79 in the past 12 months.
What is Treace Medical Concepts’s market cap?
Treace Medical Concepts’s market cap is $420.83M.
When is Treace Medical Concepts’s upcoming earnings report date?
Treace Medical Concepts’s upcoming earnings report date is Aug 12, 2025 which is in 80 days.
How were Treace Medical Concepts’s earnings last quarter?
Treace Medical Concepts released its earnings results on May 08, 2025. The company reported -$0.25 earnings per share for the quarter, beating the consensus estimate of -$0.302 by $0.052.
Is Treace Medical Concepts overvalued?
According to Wall Street analysts Treace Medical Concepts’s price is currently Undervalued.
Does Treace Medical Concepts pay dividends?
Treace Medical Concepts does not currently pay dividends.
What is Treace Medical Concepts’s EPS estimate?
Treace Medical Concepts’s EPS estimate is -0.29.
How many shares outstanding does Treace Medical Concepts have?
Treace Medical Concepts has 62,904,953 shares outstanding.
What happened to Treace Medical Concepts’s price movement after its last earnings report?
Treace Medical Concepts reported an EPS of -$0.25 in its last earnings report, beating expectations of -$0.302. Following the earnings report the stock price went down -9.549%.
Which hedge fund is a major shareholder of Treace Medical Concepts?
Currently, no hedge funds are holding shares in TMCI
Treace Medical Concepts Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.35 (64.55% Upside)
$10.35 (64.55% Upside)
Blogger Sentiment
Neutral
TMCI Sentiment 50%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 967.2K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $523.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 3.7%
Last 30 Days ▼ 3.7%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
26.55%
12-Months-Change
Fundamentals
Return on Equity
-45.73%
Trailing 12-Months
Asset Growth
-15.19%
Trailing 12-Months
Company Description
Treace Medical Concepts
Treace Medical Concepts, Inc. (TMCI) is a medical technology company focused on advancing the standard of care for orthopedic surgical procedures. The company specializes in developing and marketing innovative medical devices, particularly targeting the treatment of bunion deformities. Treace Medical Concepts is known for its Lapiplasty 3D Bunion Correction System, which aims to improve surgical outcomes and patient recovery times by addressing the root cause of bunion deformities.
TMCI Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflected a balanced view with both positive advancements in product development and market leadership, alongside continuous financial losses and modest growth expectations. While the company is expanding its portfolio and improving EBITDA, challenges persist in achieving profitability and maintaining high gross margins.Read More>TMCI Stock 12 Month Forecast
Average Price Target
$10.35
▲( 64.55% Upside)